Polyphenols and Inflammatory Bowel Disease: Natural Products With Therapeutic Effects? Publisher Pubmed



Vagharitabari M^{1, 2} ; Alemi F³ ; Zokaei M⁴ ; Moein S⁵ ; Qujeq D⁶ ; Yousefi B⁷ ; Farzami P⁸ ; Hosseininasab SS⁹
Source: Critical Reviews in Food Science and Nutrition Published:2024

Abstract

Inflammatory bowel disease (IBD) is a long-life disease with periods of recurrence and relief. Oxidative stress plays an important role in the pathogenesis of this disease. Recent years’ studies in the field of IBD treatment mostly have focused on targeting cytokines and immune cell trafficking using antibodies and inhibitors, altering the composition of intestinal bacteria in the line of attenuation of inflammation using probiotics and prebiotics, and attenuating oxidative stress through antioxidant supplementation. Studies in animal models of IBD have shown that some polyphenolic compounds including curcumin, quercetin, resveratrol, naringenin, and epigallocatechin-3-gallate can affect almost all of the above aspects and are useful compounds in the treatment of IBD. Clinical studies performed on IBD patients have also confirmed the findings of animal model studies and have shown that supplementation with some of the above-mentioned polyphenolic compounds has positive effects in reducing disease clinical and endoscopic activity, inducing and maintaining remission, and improving quality of life. In this review article, in addition to a detailed reviewing the effects of the above-mentioned polyphenolic compounds on the events involved in the pathogenesis of IBD, the results of these clinical studies will also be reviewed. © 2022 Taylor & Francis Group, LLC.